Navigation Links
Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone

NEW YORK, Oct. 13 /PRNewswire/ -- Following recent FDA approvals for prostate cancer treatment medications from Dendreon and Sanofi-Aventis, a new study shows that the lives of men with advanced prostate cancer were prolonged almost four months on Abiraterone, a new medication from Johnson & Johnson. The drug, which could reach the market in 2011, is positive prostate cancer treatment news with the potential to change clinical practice by providing a new treatment option for aggressive prostate cancer. Dr. David Samadi, a robotic surgery expert who is the Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City, described the study, which was presented at the European Society for Medical Oncology (ESMO) congress, "As yet another in a series of successful scientific steps towards fighting prostate cancer, a common, and sometimes deadly enemy."



The study followed over 1,000 men with aggressive prostate cancer and poor prognoses, who had only been given months left to live. In this group, 797 were prescribed abiraterone acetate as well as prednisone, a steroid, while the rest were given prednisone and a placebo treatment for prostate cancer. Abiraterone, discovered by Britain's Institute of Cancer Research, blocks the production of hormones that stimulate prostate cancer tumors. Abiraterone's side effects include fluid retention and hypokalemia (low levels of potassium in the blood).

The study showed that Johnson & Johnson's experimental drug not only delayed prostate cancer growth but also significantly increased the patients' life expectancy by 36%, from 10.9 to 14.8 months. The risk of death among patients on the drug also dropped by 35%. "Sure, 3.9 months does not sound like a lot of time, but in terms of the scientific history of prostate cancer, previously only four drugs had ever proven a survival potential," said Dr. Samadi, a robotic prostatectomy expert as well as a urologic oncologist with Mt. Sinai, "The discovery of this drug is even more significant because patients with the aggressive type of this disease have very limited prostate cancer treatment options and usually a terminal prognosis."

Analysts compared abiraterone to Dendreon's vaccine, Provenge, as "a nearly billion dollar opportunity" for Johnson & Johnson and "more compelling" than Sanofi-Aventis' chemotherapy, Jevtana. The latter had been approved this past June for advanced prostate cancer treatment after a study showed prolonged survival of 2.4 months. The FDA approved Provenge in April of this year for treating prostate cancer. However, sales have been impacted by limited production, which should be resolved by mid-2011. Critics says Provenge's hefty $93,000 price tag for three treatments is another sales hurdle though the company claims the price is comparable to other available treatments.

"It's been a landmark year for prostate cancer news, where we are hopefully moving towards making prostate cancer a treatable disease that the patient can survive with a specific drug treatment plan," said Dr. Samadi, "In fact, these drugs may not even be rivals, but viable prostate cancer treatment options that can be administered in a series to battle this disease."

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia, and Slovenia
2. 100,000th Patient Treated With Accurays CyberKnife® Robotic Radiosurgery System
3. With Over 3,000 Robotic Prostatectomy Surgeries to His Credit, Dr. David Samadi, MD Discusses SMART Surgery and How it Improves Sexual and Urinary Function
4. International Robotic Urology Symposium 2011
5. Health Robotics Continues Worldwide Distribution Channel Expansion in Bulgaria, Czech Republic, Romania and Slovakia
6. Robotic Prostatectomy Expert Dr. David Samadi, MD Introduces His SMART Surgery Website for Prostate Cancer Treatment Education
7. Robotic Prostatectomy Expert Dr. David Samadi, MD Talks About Prostate Cancer Treatment News and Developments
8. Robotic Surgery Expert Dr. David B. Samadi, MD Discusses New Evidence That Proves The Low Complication Rates of Robotic Prostatectomy
9. Health Robotics Continues to Dominate I.V. Automation in America, With 11 New Contracts in Second Quarter 2010
10. Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies
11. Robotic Surgeon Dr. David Samadi, MD Introduces His SMART Surgery Technique for Prostate Cancer Treatment
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... "Radioimmunoassay Market by Type (Reagents & ... Academics, Clinical Diagnostic Labs), Application (Research, Clinical ... 2020" report to their offering. ... addition of the "Radioimmunoassay Market by ...
(Date:11/25/2015)... global healthcare industry is expected to grow at a rate ... has the highest projected growth at 12.7%, and ... is second with growth projected at 11.5%. ... 2013-2014, total government funded healthcare was nearly 68%. Federal government ... 2013-2014. In real terms, out of pocket expenditure increased by ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating their ... surgeons performed their 6,000th free flap breast reconstruction surgery! , “What an accomplishment for ... excited to rebuild lives and it’s an honor to have served all of these ...
(Date:11/26/2015)... (PRWEB) , ... November 26, ... ... online platform for mental health and wellness consultation, has collaborated with Women’s ... holistically address their reader’s queries on topics on mental and emotional well-being ...
(Date:11/25/2015)... ... 25, 2015 , ... As part of a global movement ... volunteers together who want to combine talents and resources to help create sustainable ... process. The non-profit launched its first major fundraiser on November 6, 2015 at ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of the ... stellar workplace culture with the company’s Cincinnati office being named a finalist among ... was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best ...
(Date:11/25/2015)... ... 2015 , ... Ministers, senior government and UN agencies, representatives ... of Excellence, and public R&D institutions, civil societies and other partners gathered today ... African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- day ...
Breaking Medicine News(10 mins):